Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Soheila Korourian

Concepts (295)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
30
2018
1248
2.370
 Why?
Carcinoma, Ductal, Breast
9
2015
96
1.600
 Why?
Mastectomy, Segmental
8
2015
95
1.320
 Why?
Catheter Ablation
4
2014
131
1.130
 Why?
Neoplasm Recurrence, Local
7
2014
644
1.060
 Why?
Sentinel Lymph Node Biopsy
15
2017
127
1.050
 Why?
Mastectomy
9
2018
143
0.990
 Why?
Mammary Neoplasms, Experimental
7
2010
135
0.890
 Why?
Soybean Proteins
4
2023
152
0.870
 Why?
Carcinoma in Situ
3
2008
74
0.830
 Why?
Obesity
8
2023
1197
0.830
 Why?
Biopsy, Needle
10
2017
195
0.810
 Why?
Caseins
4
2023
73
0.790
 Why?
Lymph Nodes
12
2017
284
0.780
 Why?
9,10-Dimethyl-1,2-benzanthracene
4
2015
54
0.770
 Why?
Liver
9
2023
1225
0.690
 Why?
Isoflavones
5
2023
83
0.630
 Why?
DNA, Neoplasm
1
2018
171
0.620
 Why?
Rats, Zucker
9
2023
73
0.560
 Why?
Uterine Cervical Neoplasms
3
2007
276
0.510
 Why?
Receptor, erbB-2
3
2018
79
0.500
 Why?
Receptors, Estrogen
4
2018
131
0.490
 Why?
Dietary Supplements
2
2015
449
0.480
 Why?
Arginine
1
2015
182
0.480
 Why?
Aged
31
2018
10041
0.470
 Why?
Neoplasm Staging
15
2015
806
0.460
 Why?
Middle Aged
33
2018
13070
0.450
 Why?
Female
50
2018
28418
0.440
 Why?
Mammary Neoplasms, Animal
2
2015
38
0.430
 Why?
Diet
2
2015
597
0.410
 Why?
Ultrasonography, Mammary
4
2015
61
0.400
 Why?
Fatty Liver
3
2023
129
0.390
 Why?
Dehydroepiandrosterone
1
2010
16
0.380
 Why?
Carcinogens
3
2015
231
0.380
 Why?
Antigens, Tumor-Associated, Carbohydrate
2
2008
46
0.380
 Why?
Benz(a)Anthracenes
1
2010
35
0.380
 Why?
Axilla
9
2017
101
0.360
 Why?
Lymphatic Vessels
4
2014
47
0.360
 Why?
Rats
15
2023
3415
0.350
 Why?
Aged, 80 and over
14
2018
3429
0.340
 Why?
Plant Lectins
1
2008
10
0.330
 Why?
Carcinoma, Ductal
1
2008
8
0.330
 Why?
Adult
24
2018
14182
0.320
 Why?
Prognosis
11
2017
2118
0.320
 Why?
Technetium Tc 99m Sulfur Colloid
6
2014
34
0.310
 Why?
Receptors, Progesterone
4
2018
57
0.310
 Why?
Magnetic Resonance Imaging
4
2014
1604
0.310
 Why?
Electrosurgery
1
2007
10
0.300
 Why?
Lymphedema
5
2017
43
0.300
 Why?
Thinness
3
2017
57
0.290
 Why?
Cytodiagnosis
4
2015
44
0.280
 Why?
Humans
46
2019
54246
0.280
 Why?
Lymphatic Metastasis
12
2015
256
0.280
 Why?
Nipples
5
2013
34
0.270
 Why?
Prospective Studies
12
2017
2604
0.270
 Why?
Follow-Up Studies
10
2015
2387
0.270
 Why?
Combined Modality Therapy
5
2014
692
0.270
 Why?
Animals
19
2023
14385
0.260
 Why?
Adenocarcinoma, Mucinous
1
2005
23
0.260
 Why?
Endometritis
1
2004
8
0.260
 Why?
Ethanol
5
2010
322
0.250
 Why?
Proteoglycans
1
2004
96
0.250
 Why?
Radiopharmaceuticals
6
2014
238
0.240
 Why?
Carcinoma, Intraductal, Noninfiltrating
3
2013
39
0.240
 Why?
Laser Coagulation
1
2003
27
0.230
 Why?
Proliferating Cell Nuclear Antigen
1
2003
82
0.230
 Why?
Membrane Glycoproteins
1
2004
269
0.230
 Why?
Lymph Node Excision
6
2017
140
0.220
 Why?
Plasma Cells
1
2004
238
0.220
 Why?
Carcinoma, Lobular
3
2015
32
0.220
 Why?
Neoplasm Invasiveness
5
2015
295
0.220
 Why?
Coloring Agents
4
2014
84
0.220
 Why?
Mammaplasty
2
2013
45
0.210
 Why?
Infant Food
1
2002
31
0.210
 Why?
Uterine Cervical Dysplasia
3
2007
51
0.210
 Why?
Biopsy, Fine-Needle
3
2015
116
0.210
 Why?
Monitoring, Intraoperative
3
2014
66
0.200
 Why?
Ovarian Neoplasms
1
2005
472
0.190
 Why?
Immunohistochemistry
9
2017
1089
0.190
 Why?
Ultrasonography, Interventional
3
2011
146
0.180
 Why?
Paraffin Embedding
2
2018
56
0.180
 Why?
Biopsy
4
2007
692
0.180
 Why?
Sensitivity and Specificity
8
2015
923
0.170
 Why?
Lung Neoplasms
3
2015
642
0.170
 Why?
Neoplasm Grading
3
2014
131
0.170
 Why?
Body Weight
3
2017
578
0.170
 Why?
Adolescent
8
2015
6885
0.170
 Why?
Retrospective Studies
12
2015
6432
0.170
 Why?
Tissue Fixation
1
2018
35
0.160
 Why?
Specimen Handling
1
2018
62
0.160
 Why?
Alanine Transaminase
3
2015
151
0.160
 Why?
Rats, Sprague-Dawley
7
2015
1663
0.140
 Why?
Pulmonary Medicine
1
2015
15
0.140
 Why?
Protein Hydrolysates
1
2015
5
0.140
 Why?
Aspartate Aminotransferases
1
2015
57
0.130
 Why?
Kaplan-Meier Estimate
2
2014
514
0.130
 Why?
Treatment Outcome
5
2017
5604
0.130
 Why?
Rosaniline Dyes
1
2014
8
0.130
 Why?
Image-Guided Biopsy
1
2015
35
0.130
 Why?
Sulfotransferases
1
2015
43
0.130
 Why?
Dermatologic Surgical Procedures
2
2013
38
0.130
 Why?
Plant Extracts
1
2017
193
0.130
 Why?
Vacuum
2
2011
14
0.120
 Why?
Melanoma
2
2011
313
0.120
 Why?
Ultrasonography, Doppler
1
2014
57
0.120
 Why?
Young Adult
6
2015
4308
0.120
 Why?
Interleukin-6
1
2015
315
0.120
 Why?
Carcinoma, Adenoid Cystic
1
2013
10
0.110
 Why?
Patient Care Planning
1
2013
79
0.110
 Why?
Intraoperative Care
2
2011
57
0.110
 Why?
Tumor Necrosis Factor-alpha
1
2015
434
0.110
 Why?
Disease-Free Survival
1
2014
485
0.110
 Why?
Preoperative Care
1
2014
184
0.110
 Why?
Lymphography
1
2011
9
0.100
 Why?
Skin Neoplasms
2
2011
532
0.100
 Why?
Frozen Sections
1
2011
16
0.100
 Why?
Cytoprotection
1
2010
48
0.090
 Why?
DNA Methylation
1
2015
574
0.090
 Why?
Liver Neoplasms
2
2005
352
0.090
 Why?
Clinical Competence
1
2013
446
0.090
 Why?
Fatty Liver, Alcoholic
1
2010
8
0.090
 Why?
Feasibility Studies
1
2011
398
0.090
 Why?
Male
10
2023
27312
0.090
 Why?
Genistein
1
2010
46
0.090
 Why?
Drug Evaluation, Preclinical
1
2010
158
0.090
 Why?
Cell Line, Tumor
3
2010
1550
0.090
 Why?
Hepatocytes
2
2008
214
0.080
 Why?
Pilot Projects
1
2011
808
0.080
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1056
0.080
 Why?
Radionuclide Imaging
4
2011
130
0.080
 Why?
Hepatitis
1
2008
21
0.080
 Why?
Nuclear Magnetic Resonance, Biomolecular
1
2007
34
0.080
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2007
62
0.070
 Why?
Cytokines
2
2008
676
0.070
 Why?
Protons
1
2007
81
0.070
 Why?
Ovariectomy
1
2007
125
0.070
 Why?
Organ Size
1
2007
237
0.070
 Why?
Oligosaccharides
1
2005
45
0.070
 Why?
Cystadenocarcinoma, Papillary
1
2005
15
0.070
 Why?
Omentum
1
2005
13
0.070
 Why?
Antibodies, Neoplasm
1
2005
35
0.070
 Why?
Uterine Neoplasms
1
2005
63
0.070
 Why?
Monosaccharide Transport Proteins
1
2004
15
0.060
 Why?
Eosine Yellowish-(YS)
1
2004
6
0.060
 Why?
Carcinoma, Small Cell
1
2004
28
0.060
 Why?
Syndecans
1
2004
43
0.060
 Why?
Hematoxylin
1
2004
8
0.060
 Why?
Syndecan-1
1
2004
82
0.060
 Why?
Endometrium
1
2004
43
0.060
 Why?
Aging
1
2010
784
0.060
 Why?
Endotoxins
1
2004
37
0.060
 Why?
Immunoenzyme Techniques
1
2004
165
0.060
 Why?
Liver Diseases, Alcoholic
1
2004
35
0.060
 Why?
Lymphoma, Non-Hodgkin
1
2004
63
0.060
 Why?
Carbohydrates
1
2004
64
0.060
 Why?
Cytological Techniques
1
2003
15
0.060
 Why?
Apoproteins
1
2003
11
0.060
 Why?
Neoplasms, Multiple Primary
1
2003
45
0.060
 Why?
Malondialdehyde
1
2003
63
0.060
 Why?
Dietary Fats
1
2004
142
0.060
 Why?
Fatty Acids
1
2004
174
0.060
 Why?
Gene Expression
2
2019
664
0.060
 Why?
Aldehydes
1
2003
97
0.060
 Why?
Cytochrome P-450 CYP2E1
3
2010
105
0.060
 Why?
Neoplasms
2
2004
1315
0.060
 Why?
Cell Membrane
1
2004
278
0.060
 Why?
Gene Expression Regulation
1
2008
1062
0.050
 Why?
Overweight
1
2005
239
0.050
 Why?
Risk Factors
1
2011
3930
0.050
 Why?
Asia
1
2002
32
0.050
 Why?
Image Processing, Computer-Assisted
1
2003
256
0.050
 Why?
Chronic Disease
1
2004
612
0.050
 Why?
Cost-Benefit Analysis
2
2015
291
0.050
 Why?
Carcinoma, Squamous Cell
1
2004
384
0.050
 Why?
Head and Neck Neoplasms
1
2004
335
0.050
 Why?
Cytokine Receptor Common beta Subunit
1
2019
2
0.050
 Why?
Neoplasm Metastasis
2
2015
252
0.050
 Why?
Methyltransferases
1
2019
28
0.050
 Why?
Time Factors
1
2007
3212
0.040
 Why?
Health Status
1
2002
368
0.040
 Why?
Disease Progression
2
2015
913
0.040
 Why?
Alcohol Dehydrogenase
2
2010
31
0.040
 Why?
Child, Preschool
1
2008
4146
0.040
 Why?
Cohort Studies
2
2015
1543
0.040
 Why?
Apoptosis
1
2005
1300
0.040
 Why?
Stereotaxic Techniques
2
2010
36
0.040
 Why?
Arm
2
2009
52
0.040
 Why?
Hematoma
2
2010
60
0.040
 Why?
Anti-Bacterial Agents
1
2004
820
0.040
 Why?
Polymerase Chain Reaction
1
2019
531
0.040
 Why?
Oxidative Stress
3
2010
958
0.040
 Why?
Risk Assessment
2
2017
1361
0.040
 Why?
Feces
1
2017
135
0.040
 Why?
Injections, Intralesional
2
2008
38
0.040
 Why?
Adiponectin
1
2017
76
0.040
 Why?
Reproducibility of Results
2
2015
1304
0.040
 Why?
Phylogeny
1
2017
269
0.040
 Why?
Disease Models, Animal
2
2015
1639
0.030
 Why?
Lipid Metabolism
1
2017
194
0.030
 Why?
Leptin
1
2017
154
0.030
 Why?
Cost Savings
1
2015
67
0.030
 Why?
Protective Agents
1
2015
20
0.030
 Why?
Child
1
2008
7337
0.030
 Why?
Taxoids
1
2015
45
0.030
 Why?
MCF-7 Cells
1
2015
79
0.030
 Why?
CpG Islands
1
2015
104
0.030
 Why?
Mice, Inbred BALB C
2
2005
368
0.030
 Why?
Cyclophosphamide
1
2015
172
0.030
 Why?
Insulin
1
2017
510
0.030
 Why?
Infant, Newborn
1
2002
2907
0.030
 Why?
Touch
1
2013
27
0.030
 Why?
Tumor Cells, Cultured
1
2015
477
0.030
 Why?
Neoadjuvant Therapy
1
2015
125
0.030
 Why?
Biopsy, Large-Core Needle
1
2013
31
0.030
 Why?
Carcinoma
1
2015
153
0.030
 Why?
Angiogenesis Inhibitors
1
2015
203
0.030
 Why?
Infant
1
2002
3817
0.030
 Why?
Radiotherapy, Adjuvant
1
2013
66
0.030
 Why?
Hormones
1
2013
59
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
240
0.030
 Why?
Chemotherapy, Adjuvant
1
2013
119
0.030
 Why?
Injections, Intradermal
1
2011
15
0.030
 Why?
X-Rays
1
2011
57
0.030
 Why?
Cicatrix
1
2011
43
0.020
 Why?
Intraoperative Period
1
2011
51
0.020
 Why?
United States
1
2002
5200
0.020
 Why?
Antineoplastic Agents
2
2013
1300
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2015
866
0.020
 Why?
Diagnosis, Differential
2
2004
1136
0.020
 Why?
Allyl Compounds
1
2010
9
0.020
 Why?
Sulfides
1
2010
32
0.020
 Why?
Predictive Value of Tests
2
2004
1048
0.020
 Why?
Survival Rate
1
2012
951
0.020
 Why?
Chemokines
1
2010
96
0.020
 Why?
Mammary Glands, Animal
1
2010
69
0.020
 Why?
Transforming Growth Factor beta1
1
2010
66
0.020
 Why?
Double-Blind Method
1
2011
742
0.020
 Why?
Pyrazoles
1
2010
110
0.020
 Why?
Endoplasmic Reticulum
1
2010
123
0.020
 Why?
Cell Division
1
2010
330
0.020
 Why?
Tissue Extracts
1
2007
13
0.020
 Why?
Least-Squares Analysis
1
2007
45
0.020
 Why?
Solubility
1
2007
75
0.020
 Why?
Electrocoagulation
1
2007
10
0.020
 Why?
Pregnancy
1
2015
2620
0.020
 Why?
Biotransformation
1
2007
100
0.020
 Why?
Enteral Nutrition
1
2008
136
0.020
 Why?
Survival Analysis
1
2009
735
0.020
 Why?
Enzyme Inhibitors
1
2010
446
0.020
 Why?
Observer Variation
1
2007
138
0.020
 Why?
Staining and Labeling
1
2007
106
0.020
 Why?
Positron-Emission Tomography
1
2008
322
0.020
 Why?
E-Selectin
1
2005
19
0.020
 Why?
Body Weights and Measures
1
2005
19
0.020
 Why?
Wheat Germ Agglutinins
1
2005
4
0.020
 Why?
Vaccines, Subunit
1
2005
20
0.020
 Why?
Vaccines, DNA
1
2005
22
0.020
 Why?
Cross Reactions
1
2005
56
0.020
 Why?
Cytotoxicity, Immunologic
1
2005
62
0.020
 Why?
Growth Inhibitors
1
2005
32
0.020
 Why?
Gadolinium
1
2005
54
0.020
 Why?
Gene Amplification
1
2005
57
0.020
 Why?
Ligands
1
2005
230
0.020
 Why?
Glucose Transporter Type 1
1
2004
16
0.020
 Why?
Sampling Studies
1
2004
40
0.020
 Why?
Free Radicals
1
2004
31
0.020
 Why?
Imaging, Three-Dimensional
1
2005
171
0.020
 Why?
Enzyme Induction
1
2004
80
0.020
 Why?
Corn Oil
1
2004
13
0.020
 Why?
In Situ Hybridization, Fluorescence
1
2005
278
0.020
 Why?
Mice
2
2005
6413
0.020
 Why?
MART-1 Antigen
1
2004
12
0.020
 Why?
Eye Neoplasms
1
2004
10
0.020
 Why?
Hyperplasia
1
2004
107
0.020
 Why?
Species Specificity
1
2004
205
0.010
 Why?
Contrast Media
1
2005
221
0.010
 Why?
Injections
1
2003
61
0.010
 Why?
Dietary Carbohydrates
1
2004
89
0.010
 Why?
Rats, Wistar
1
2004
237
0.010
 Why?
Necrosis
1
2004
208
0.010
 Why?
Cell Proliferation
1
2008
1096
0.010
 Why?
Amino Acid Sequence
1
2005
767
0.010
 Why?
Cytoplasm
1
2004
108
0.010
 Why?
Regression Analysis
1
2004
445
0.010
 Why?
Molecular Sequence Data
1
2005
980
0.010
 Why?
Cytochrome P-450 Enzyme System
1
2004
192
0.010
 Why?
Cell Nucleus
1
2004
203
0.010
 Why?
Energy Intake
1
2004
196
0.010
 Why?
Antigens, Neoplasm
1
2004
170
0.010
 Why?
Multivariate Analysis
1
2004
643
0.010
 Why?
Glutathione
1
2004
330
0.010
 Why?
Sex Characteristics
1
2004
214
0.010
 Why?
Confidence Intervals
1
2002
167
0.010
 Why?
Antioxidants
1
2004
297
0.010
 Why?
Neoplasm Proteins
1
2004
359
0.010
 Why?
Korourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (295) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department